Volnea
Product Images NDC 53002-1813

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Volnea (NDC 53002-1813). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig-1 (Fig 1)

A forest plot chart showing effect estimates (odds ratios/risk ratios) with confidence intervals from multiple studies related to contraceptive use outcomes, including the NICHD Women's Contraceptive Study, French E3N cohort Study, Shanghai Women's Health Study, Nurses' Health Study II, Oxford Family Planning Association Study, and Danish Sex Hormone Register Study. The horizontal axis displays effect estimates ranging approximately from -1.5 to 2.*

FDA Label Image

Structure Formula (Image 01)

Chemical structure diagrams of the active ingredients Desogestrel and Ethinyl Estradiol shown with their molecular formulas C22H30O and C20H24O2, respectively. The structures depict the molecular arrangement of these hormone compounds commonly used in contraceptive medications.*

FDA Label Image

Label Image (Lbl530021813)

Volnea Tablets 28-Day Pack label from RPK Pharmaceuticals, Inc. The label specifies a 28-day regimen with instructions to take 1 tablet daily as directed. It includes multiple NDC numbers for billing, barcode, and placeholders for clinic and patient information. The label is primarily black and white with detailed text instructions and regulatory information.*

FDA Label Image

Volnea-blister-1.jpg (Volnea Blister 1)

Volnea desogestrel and ethinyl estradiol tablets blister pack showing 28 daily-dose circular tablets arranged for a 4-week cycle, labeled with days of the week and week numbers. The packaging also includes dosage strengths 0.15 mg/0.02 mg and 0.01 mg, and the labeler RPK Pharmaceuticals, Inc.*

FDA Label Image

Volnea-blister-2.jpg (Volnea Blister 2)

An instructional illustration showing a hand removing a tablet from a Volnea blister pack. The pack is organized in a 4-week layout with days of the week labeled for daily oral dosing guidance.*

FDA Label Image

Volnea-blister-3.jpg (Volnea Blister 3)

An instructional blister pack diagram for Volnea, showing the weekly sequence of tablet consumption. The pack includes weeks 1 to 4 labeled Sunday to Saturday, with white, yellow, and green tablets identified by color-coded labels. Directions indicate starting on Sunday and taking the tablets in order.*

FDA Label Image

Volnea-figure-1.jpg (Volnea Figure 1)

A bar chart depicting mortality rates (number of deaths per 100,000 woman-years) across different age groups (15-24, 25-34, 35-44, 45+) categorized by four groups: ever-users (non-smokers), ever-users (smokers), controls (non-smokers), and controls (smokers). Mortality rates increase with age, with ever-users (smokers) showing notably higher rates in older age groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.